FierceBiotech
A year and a half into a strategic partnership using PathoQuest’s next-generation sequencing (NGS) services, Charles River Laboratories appears happy with what it gets and intends to make a direct investment in PathoQuest.
Charles River partnered with PathoQuest in September 2016 to offer clients NGS solutions for biologics viral contamination testing and cell-line genetic characterization, as well as viral safety testing of other materials used in the development of biologics.